JPS5775916A - Coenzyme q pharmaceutical and its preparation - Google Patents

Coenzyme q pharmaceutical and its preparation

Info

Publication number
JPS5775916A
JPS5775916A JP15071780A JP15071780A JPS5775916A JP S5775916 A JPS5775916 A JP S5775916A JP 15071780 A JP15071780 A JP 15071780A JP 15071780 A JP15071780 A JP 15071780A JP S5775916 A JPS5775916 A JP S5775916A
Authority
JP
Japan
Prior art keywords
coenzyme
pharmaceutical
solvent
aqueous
lecithin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15071780A
Other languages
Japanese (ja)
Inventor
Mitsuo Mazaki
Sadao Ohira
Morio Hirano
Keiko Nishikatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Chemiphar Co Ltd
Original Assignee
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co Ltd filed Critical Nippon Chemiphar Co Ltd
Priority to JP15071780A priority Critical patent/JPS5775916A/en
Publication of JPS5775916A publication Critical patent/JPS5775916A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)

Abstract

PURPOSE:To obtain an aqueous coenzyme Q pharmaceutical, containing many ribosomes of a specific amount of lecithin containing a specified amount of dispersed coenzyme Q in an emulsified state, having improved absorbability substantially without ethanol with no limitation on use. CONSTITUTION:One pt.wt. coenzyme Q and 15-100pts.wt. lecithin are dissolved in a solvent capable of dissolving both substances easily, preferably an organic solvent having a dipole moment value <=1.5 (in the liquid phase) and a high volatility or a 3-7C carboxylic ester, and then the solvent is removed. The resultant residue is then emulsified in an aqueous solvent to give an aqueous coenzyme Q pharmaceutical containing many ribosomes of lecithin containing dispersed coenzyme Q in the proportion described above in an emulsified state and substantially no ethanol. The resultant pharmaceutical has improved absorbability in digestive tracts and is useful for the treatment of angina pectoris, etc. by the oral administration.
JP15071780A 1980-10-29 1980-10-29 Coenzyme q pharmaceutical and its preparation Pending JPS5775916A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15071780A JPS5775916A (en) 1980-10-29 1980-10-29 Coenzyme q pharmaceutical and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15071780A JPS5775916A (en) 1980-10-29 1980-10-29 Coenzyme q pharmaceutical and its preparation

Publications (1)

Publication Number Publication Date
JPS5775916A true JPS5775916A (en) 1982-05-12

Family

ID=15502861

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15071780A Pending JPS5775916A (en) 1980-10-29 1980-10-29 Coenzyme q pharmaceutical and its preparation

Country Status (1)

Country Link
JP (1) JPS5775916A (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0083108A2 (en) * 1981-12-28 1983-07-06 Eisai Co., Ltd. Aqueous solution containing ubidecarenone
WO1984002076A1 (en) * 1982-11-26 1984-06-07 Fluidcarbon International Ab Method of preparing controlled-release preparations for biologically active materials and resulting compositions
JPS6012127A (en) * 1983-06-30 1985-01-22 Dai Ichi Seiyaku Co Ltd Preparing method of liposome
FR2562422A1 (en) * 1984-04-09 1985-10-11 Seuref Ag PHARMACEUTICAL COMPOSITIONS WITH ACTION ANTI-ANOXIC AND METABOLIC CEREBRAL
JP2003169633A (en) * 2001-12-06 2003-06-17 Sukoyaka Shokuhin Kk Nutritional supplementary food having various effects such as blood presser lowering heart reinforcement, arteriosclerosis prevention, blood vessel protection, anti-fatigue, motor function improvement, energy metabolism efficiency improvement, and anti-oxidation
WO2004082668A1 (en) * 2003-03-20 2004-09-30 Shanghaijahwa United Co., Ltd. Coenzyme q10-containing proliposome and preparation thereof
JP2007518805A (en) * 2004-01-22 2007-07-12 ユニバーシティー・オブ・マイアミ Topical coenzyme Q10 formulation and method of use
US9896731B2 (en) 2009-05-11 2018-02-20 Berg Llc Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10)
US9901542B2 (en) 2013-09-04 2018-02-27 Berg Llc Methods of treatment of cancer by continuous infusion of coenzyme Q10
US10376477B2 (en) 2011-04-04 2019-08-13 Berg Llc Method of treating or preventing tumors of the central nervous system
US10668028B2 (en) 2008-04-11 2020-06-02 Berg Llc Methods and use of inducing apoptosis in cancer cells
US10933032B2 (en) 2013-04-08 2021-03-02 Berg Llc Methods for the treatment of cancer using coenzyme Q10 combination therapies

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52114013A (en) * 1976-03-22 1977-09-24 Yoshitomi Pharmaceut Ind Ltd Trapping of active sbustance into liposome
JPS5356315A (en) * 1976-11-01 1978-05-22 Eisai Co Ltd Emulsified solution of fat soluble drugs
JPS53142514A (en) * 1977-05-10 1978-12-12 Ici Ltd Freeze dried latent liposome mixture * aqueous liposome preparation and production thereof
JPS5459314A (en) * 1977-09-30 1979-05-12 Farmaceutici Italia Minute fat globule suspension

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52114013A (en) * 1976-03-22 1977-09-24 Yoshitomi Pharmaceut Ind Ltd Trapping of active sbustance into liposome
JPS5356315A (en) * 1976-11-01 1978-05-22 Eisai Co Ltd Emulsified solution of fat soluble drugs
JPS53142514A (en) * 1977-05-10 1978-12-12 Ici Ltd Freeze dried latent liposome mixture * aqueous liposome preparation and production thereof
JPS5459314A (en) * 1977-09-30 1979-05-12 Farmaceutici Italia Minute fat globule suspension

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0083108A2 (en) * 1981-12-28 1983-07-06 Eisai Co., Ltd. Aqueous solution containing ubidecarenone
WO1984002076A1 (en) * 1982-11-26 1984-06-07 Fluidcarbon International Ab Method of preparing controlled-release preparations for biologically active materials and resulting compositions
JPS6012127A (en) * 1983-06-30 1985-01-22 Dai Ichi Seiyaku Co Ltd Preparing method of liposome
JPH0457375B2 (en) * 1983-06-30 1992-09-11 Daiichi Seiyaku Co
FR2562422A1 (en) * 1984-04-09 1985-10-11 Seuref Ag PHARMACEUTICAL COMPOSITIONS WITH ACTION ANTI-ANOXIC AND METABOLIC CEREBRAL
US4684520A (en) * 1984-04-09 1987-08-04 Seuref A.G. Pharmaceutical compositions having cerebral antianoxic and metabolic activities
JP2003169633A (en) * 2001-12-06 2003-06-17 Sukoyaka Shokuhin Kk Nutritional supplementary food having various effects such as blood presser lowering heart reinforcement, arteriosclerosis prevention, blood vessel protection, anti-fatigue, motor function improvement, energy metabolism efficiency improvement, and anti-oxidation
WO2004082668A1 (en) * 2003-03-20 2004-09-30 Shanghaijahwa United Co., Ltd. Coenzyme q10-containing proliposome and preparation thereof
US8586030B2 (en) 2004-01-22 2013-11-19 University Of Miami Co-enzyme Q10 formulations and methods of use
JP2007518805A (en) * 2004-01-22 2007-07-12 ユニバーシティー・オブ・マイアミ Topical coenzyme Q10 formulation and method of use
US8771680B2 (en) 2004-01-22 2014-07-08 University Of Miami Topical co-enzyme Q10 formulations and methods of use
US8562976B2 (en) 2004-01-22 2013-10-22 University Of Miami Co-enzyme Q10 formulations and methods of use
US10668028B2 (en) 2008-04-11 2020-06-02 Berg Llc Methods and use of inducing apoptosis in cancer cells
US9896731B2 (en) 2009-05-11 2018-02-20 Berg Llc Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10)
US11028446B2 (en) 2009-05-11 2021-06-08 Berg Llc Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10)
US10351915B2 (en) 2009-05-11 2019-07-16 Berg Llc Methods for treatment of oncological disorders using an epimetabolic shifter (Coenzyme Q10)
US10519504B2 (en) 2009-05-11 2019-12-31 Berg Llc Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
US10376477B2 (en) 2011-04-04 2019-08-13 Berg Llc Method of treating or preventing tumors of the central nervous system
US11452699B2 (en) 2011-04-04 2022-09-27 Berg Llc Method of treating or preventing tumors of the central nervous system
US10933032B2 (en) 2013-04-08 2021-03-02 Berg Llc Methods for the treatment of cancer using coenzyme Q10 combination therapies
US9901542B2 (en) 2013-09-04 2018-02-27 Berg Llc Methods of treatment of cancer by continuous infusion of coenzyme Q10
US11298313B2 (en) 2013-09-04 2022-04-12 Berg Llc Methods of treatment of cancer by continuous infusion of coenzyme Q10

Similar Documents

Publication Publication Date Title
JPS5775916A (en) Coenzyme q pharmaceutical and its preparation
RU94028887A (en) MIXTURE OF HIGHER PRIMARY ALIPHATIC ALCOHOLS, METHOD FOR ITS PREPARATION, PHARMACEUTICAL COMPOSITION BASED ON
CA1163199A (en) Aqueous solution of nitroglycerin
KR890700036A (en) Nasal preparations and preparation methods thereof
DE69426984D1 (en) MEDICINE PREPARATION
KR880009662A (en) IGF-II-containing drugs
IE861813L (en) New Polysaccharide Esters and their Salts
GR3017411T3 (en) Production process of microspheres.
JPS542316A (en) Solid pharmaceutical composition containing nifedipene
IE45439L (en) Penicillanic acid derivatives
ATE67406T1 (en) PREPARATION FOR INJECTION CONTAINING NICORANDIL.
KR880009018A (en) 3-L-pyroglutamyl-L-thiazolidine-4-carboxylic acid and its preparation
JPS5446837A (en) Easily absorbable nifedipin composition, its preparation, and anti-stenocardia containing the same
DE3882984D1 (en) PRODUCTION OF A SOLUTION CONSISTING OF A PHARMACOLOGICAL ACTIVE SUBSTANCE AND A LIPID.
JPS5218811A (en) Preparation of aqueous solution of fat- soluble substances
JPS5225015A (en) Process for preparing fine granular drugs
JPS5283428A (en) Preparation of aromatic carboxylic acid amide derivatives
KR890012960A (en) Crystalline β-lactam Solvate
ATE2746T1 (en) PIPERIDINE DERIVATIVES OF 4,5-DIALKYL-3-HYDROXYPYRROL-2-CARBONS[UREESTERS, THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
EP0023355A3 (en) Medicinal solutions and process for their preparation
RU95109859A (en) TABLET, CAPSULE OR GRANULA CONTAINING DESOGESTREL, ITS APPLICATION, METHOD FOR INTRODUCING DESOGESTREL AND OPTIONAL ESTROGEN IN SOLID
JPS525769A (en) Preparation of 3-substituted pyrolidine derivatives
ATE4808T1 (en) PIPERIDINE DERIVATIVES OF 3-HYDROXY-THIOPHEN-2CARBONS[UREESTERS, THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
KR880012518A (en) Analgesic and anti-inflammatory pharmaceutical compositions containing naphthal-acetic acid derivatives
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives